| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 144 |
| 1 | ASPIRIN | 142 |
| 2 | ASPIRIN 81 MG | 138 |
| 3 | ASPIRIN 325 MG | 137 |
| 4 | CARVEDILOL | 127 |
| 5 | LISINOPRIL | 79 |
| 6 | METOPROLOL TARTRATE | 76 |
| 7 | CLOPIDOGREL | 75 |
| 8 | DIGOXIN | 74 |
| 9 | ATORVASTATIN CALCIUM | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUCCIMER | 1 | 0.0141 |
| 1 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 4 | 0.0093 |
| 2 | AFICAMTEN | 4 | 0.0080 |
| 3 | GUAIFENESIN AND CODEINE PHOSPHATE | 1 | 0.0075 |
| 4 | QUINIDINE SULFATE TABLET | 1 | 0.0070 |
| 5 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 6 | RANOLAZINE | 67 | 0.0064 |
| 7 | MIGALASTAT HYDROCHLORIDE | 3 | 0.0054 |
| 8 | SODIUM NITROPRUSSIDE | 2 | 0.0052 |
| 9 | MEXILETINE HYDROCHLORIDE | 2 | 0.0048 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 167 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 163 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 145 |
| 3 | beta-Adrenergic Blocker [EPC] | 142 |
| 4 | alpha-Adrenergic Blocker [EPC] | 128 |
| 5 | Insulin Analog [EPC] | 88 |
| 6 | Aldosterone Antagonist [EPC] | 79 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 75 |
| 8 | Cardiac Glycoside [EPC] | 74 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 71 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lead Chelator [EPC] | 1 | 0.0119 |
| 1 | Anti-anginal [EPC] | 67 | 0.0064 |
| 2 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 3 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 4 | Cardiac Glycoside [EPC] | 74 | 0.0010 |
| 5 | alpha-Adrenergic Blocker [EPC] | 128 | 0.0009 |
| 6 | Antihypoglycemic Agent [EPC] | 3 | 0.0007 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 6 | 0.0006 |
| 8 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 9 | Nitrate Vasodilator [EPC] | 51 | 0.0006 |